secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001493152-23-005140
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical completes SPAC merger; begins trading on Nasdaq under "OCEA"
-----------------------------------------------------------------------------

- Completed business combination with Aesther Healthcare Acquisition Corp.; begins trading on Nasdaq on Feb. 15, 2023 under ticker OCEA.
- Secured up to $60M backstop from Vellar Opportunity Fund and $75M equity line from White Lion Capital.
- Pipeline focused on oncology, pulmonary fibrosis, and infectious disease supported by $123.9M in grants.
- Leadership: Elizabeth Ng CEO, Dr. Chirinjeev Kathuria Executive Chairman, Dr. Jack Elias Scientific Advisory Board Chair.
- Board of directors includes Suren Ajjarapu, Michael Peterson, Martin D. Angle, Dr. Michelle Berry, Jerome Ringo, Gov. William Owens.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223005140/0001493152-23-005140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223005140/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer